EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access

Integrating Electronic Patient-Reported Outcomes and Palliative Care in Pediatric Advanced Cancer: The PediQUEST Response Multisite Randomized Controlled Trial

Veronica Dussel iD, Liliana Orellana, Maria L Requena, Madeline Avery, Denise Becker iD, Christina K Ullrich iD, Chris Feudtner iD, Jason L Freedman iD, Tammy I Kang, Elisha D Waldman, Cynthia A Gerhardt, Marie A Bakitas iD und 4 weitere

Journal of Clinical Oncology · 2026

DOI: 10.1200/jco-25-01036 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Oncology, 2026. Verfasst von Veronica Dussel und 15 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Palliative Care Research and Innovation Lab, MassGeneral for Children, Boston, MA. Hauptthemen laut MEDLINE: Palliative Care, Patient Reported Outcome Measures, Neoplasms. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE We conducted the PediQUEST Response to the Pediatric Oncology Symptom Experience (PQ Response) randomized controlled trial (RCT) to assess whether combining feedback from an electronic patient-reported outcome (ePRO) system with specialized pediatric palliative care (SPPC) consultation improved health-related quality of life (HRQOL) in children with advanced cancer. METHODS This multicenter open-label RCT enrolled children 2 years and older with advanced cancer. The study was conducted between April 2018 and December 2021 at five US tertiary-level pediatric cancer centers. All parents and children 5 years and older answered weekly child HRQOL and symptom surveys over 18 weeks (2-week run-in). Child-parent dyads were assigned (1:1) to PQ Response (n = 74) or usual care (n = 80) for 16 weeks. Primary outcomes were the difference between average 16-week and baseline Pediatric Quality of Life Inventory (PedsQL-4.0) total scores reported by parents and children (range, 0-100; higher = better HRQOL; minimal clinically important difference [MCID], 4.5). Secondary outcomes were PedsQL subscales and symptom scores. Analyses followed an intention-to-treat approach. RESULTS Of 154 participants randomly assigned, 50% were girls, 78% were White, 17% were Hispanic, and 45% had brain tumors. The mean age was 11 years (standard deviation, 6.1). Parents assigned to PQ Response reported greater improvements in child HRQOL (PedsQL total mean difference 3.45 points [{95% CI, 0.48 to 6.43}; P = .023]; PedsQL physical 4.61 [{95% CI, 0.40 to 8.82}; P = .032]). Children reported similar improvements. Effects did not exceed MCIDs. No improvements were observed in PedsQL-psychosocial or symptom scores. Sensitivity analyses showed consistent effects, with most physical HRQOL scores and several child-reported symptom scores exceeding MCIDs. We observed site-specific variability. At the site with the largest adherence, all effects exceeded MCIDs. No adverse events reported. CONCLUSION Findings suggest benefits of integrating electronic patient-reported outcome feedback and SPPC into pediatric advanced cancer care. Enhanced implementation strategies are needed to optimize clinical impact.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Palliative CarePatient Reported Outcome MeasuresNeoplasmsHumansFemaleChildMaleQuality of LifeAdolescentChild, Preschool

Autor:innen und Institutionen

  • Pediatric Palliative Care Research and Innovation Lab, MassGeneral for Children, Boston, MA.
  • Biostatistics Unit, Deakin University, Geelong, VIC, Australia.
  • Center for Research and Implementation in Palliative Care, Buenos Aires, Argentina.
  • Department of Supportive Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Department of Pediatrics, Boston Children's Hospital, Boston, MA.

ORCID-Profile: Veronica Dussel, Denise Becker, Christina K Ullrich, Chris Feudtner, Jason L Freedman, Marie A Bakitas, Stefan J Friedrichsdorf, Abby R Rosenberg, Joanne Wolfe

Förderung

  • NINR NIH HHS

Zitieren

APA

Dussel, V., Orellana, L., Requena, M. L., Avery, M., Becker, D., Ullrich, C. K., Feudtner, C., Freedman, J. L., Kang, T. I., Waldman, E. D., Gerhardt, C. A., Bakitas, M. A., Baker, J. N., Friedrichsdorf, S. J., Rosenberg, A. R., & Wolfe, J. (2026). Integrating Electronic Patient-Reported Outcomes and Palliative Care in Pediatric Advanced Cancer: The PediQUEST Response Multisite Randomized Controlled Trial. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-01036

Vancouver

Dussel V, Orellana L, Requena ML, Avery M, Becker D, Ullrich CK, et al. Integrating Electronic Patient-Reported Outcomes and Palliative Care in Pediatric Advanced Cancer: The PediQUEST Response Multisite Randomized Controlled Trial. Journal of Clinical Oncology. 2026. doi:10.1200/jco-25-01036

BibTeX
@article{Dussel2026,
  author = {Dussel, Veronica and Orellana, Liliana and Requena, Maria L and Avery, Madeline and Becker, Denise and Ullrich, Christina K and Feudtner, Chris and Freedman, Jason L and Kang, Tammy I and Waldman, Elisha D and Gerhardt, Cynthia A and Bakitas, Marie A and Baker, Justin N and Friedrichsdorf, Stefan J and Rosenberg, Abby R and Wolfe, Joanne},
  title = {Integrating Electronic Patient-Reported Outcomes and Palliative Care in Pediatric Advanced Cancer: The PediQUEST Response Multisite Randomized Controlled Trial},
  journal = {Journal of Clinical Oncology},
  year = {2026},
  doi = {10.1200/jco-25-01036}
}
Kostenlos starten →